Acinetobacter calcoaceticus from a fatal case of pneumonia harboring blaNDM-1 on a widely distributed plasmid

BMC Infectious Diseases

Volumn 15, Issue 1, 2015, Pages

  Li, Peng ^a   Yang, Chaojie ^a   Xie, Jing ^a   Liu, Nan ^a   Wang, Houzhao ^b   Zhang, Ling ^b   Wang, Xu ^a   Wang, Yong ^a   Qiu, Shaofu ^a   Song, Hongbin ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b The Affiliated Chenggong Hospital of Xiamen University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CARBAPENEMASE; CEFAZOLIN; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MINOCYCLINE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RNA 16S; SULTAMICILLIN; TETRACYCLINE; TIGECYCLINE; ANTIINFECTIVE AGENT; BETA LACTAMASE; BETA-LACTAMASE NDM-1; TRANSPOSON;

ACINETOBACTER CALCOACETICUS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL PNEUMONIA; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLANDM 1 GENE; BLAOXA 75 GENE; CHINA; CONTROLLED STUDY; FATALITY; GENE; GENE DOSAGE; GENE IDENTIFICATION; GENE INSERTION; GENE LOCATION; GENE SEQUENCE; GENE TRANSFER; GEOGRAPHIC DISTRIBUTION; HUMAN; ISABA125 GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYLOGENY; PLASMID; PROMOTER REGION; PULSED FIELD GEL ELECTROPHORESIS; RNA SEQUENCE; SEQUENCE HOMOLOGY; SPUTUM ANALYSIS; STRAIN IDENTIFICATION; TRANSPOSON; WHOLE GENOME SEQUENCE; ACINETOBACTER; ACINETOBACTER INFECTION; CASE REPORT; DRUG EFFECTS; GENETICS; HORIZONTAL GENE TRANSFER; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; SEQUENCE ANALYSIS;

ACINETOBACTER; ACINETOBACTER CALCOACETICUS; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CHINA; DNA TRANSPOSABLE ELEMENTS; ELECTROPHORESIS, GEL, PULSED-FIELD; FATAL OUTCOME; GENE TRANSFER, HORIZONTAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PLASMIDS; PNEUMONIA, BACTERIAL; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, RNA;

EID: 84925357900     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-015-0870-7     Document Type: Article

References (45)

1. Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA. Carbapenems: past, present, and future. Antimicrob Agents Chemother. 2011;55:4943-60.
2. Perez F, Van Duin D. Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients. Cleve Clin J Med. 2013;80:225-33.
3. Nordmann P, Naas T, Poirel L. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011;17:1791-8.
4. Woodford N, Wareham DW, Guerra B, Teale C. Carbapenemase-producing Enterobacteriaceae and non-Enterobacteriaceae from animals and the environment: an emerging public health risk of our own making? J Antimicrob Chemother. 2014;69:287-91.
5. NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009;53:5046-54.
6. Charan J, Mulla S, Ryavanki S, Kantharia N. New Delhi Metallo-β -lactamase-1 containing enterobacteriaceae: origin, diagnosis, treatment and public health concern. Pan Afr Med J. 2012;11:22.
7. Muir A, Weinbren MJ. New Delhi metallo-β -lactamase: a cautionary tale. J Hosp Infect. 2010;75:239-40.
8. IMP in pan-drug resistant Acinetobacter baumannii isolates in China. Clin Infect Dis. 2011;52:692-3.
9. Chen Y, Zhou Z, Jiang Y, Yu Y. Emergence of NDM-1-producing Acinetobacter baumannii in China. J Antimicrob Chemother. 2011;66:1255-9.
10. Ho P-L, Li Z, Lai EL, Chiu SS, Cheng VCC. Emergence of NDM-1-producing Enterobacteriaceae in China. J Antimicrob Chemother. 2012;67:1553-5.
11. NDM-1 among Klebsiella pneumoniae ST15 and novel ST1031 clinical isolates in China. Diagn Microbiol Infect Dis. 2013;75:373-6.
12. Liu Z, Li W, Wang J, Pan J, Sun S, Yu Y, et al. Identification and characterization of the first Escherichia coli strain carrying NDM-1 gene in China. PLoS One. 2013;8:e66666.
13. Wang X, Liu W, Zou D, Li X, Wei X, Shang W, et al. High rate of New Delhi Metallo-β -Lactamase 1-producing bacterial infection in China. Clin Infect Dis. 2013;56:161-2.
14. Zhang C, Qiu S, Wang Y, Qi L, Hao R, Liu X, et al. Higher isolation of NDM-1 producing Acinetobacter baumannii from the sewage of the hospitals in Beijing. PLoS One. 2013;8:e64857.
15. Yang J, Chen Y, Jia X, Luo Y, Song Q, Zhao W, et al. Dissemination and characterization of NDM-1-producing Acinetobacter pittii in an intensive care unit in China. Clin Microbiol Infect. 2012;18:E506-13.
16. Wang Y, Wu C, Zhang Q, Qi J, Liu H, Wang Y, et al. Identification of New Delhi metallo-β -lactamase 1 in Acinetobacter lwoffii of food animal origin. PLoS One. 2012;7:e37152.
17. NDM-1-carrying plasmid pNDM-AB from Acinetobacter baumannii of food animal origin. J Antimicrob Chemother. 2013;68:1681-2.
18. Rolain JM, Parola P, Cornaglia G. New Delhi metallo-β -lactamase (NDM-1): towards a new pandemia? Clin Microbiol Infect. 2010;16:1699-701.
19. NDM-1-carrying Acinetobacter johnsonii detected in hospital sewage. J Antimicrob Chemother. 2013;68:1007-10.
20. NDM-1 gene and type IV secretion system in clinical isolates of Acinetobacter lwoffii. Antimicrob Agents Chemother. 2012;56:1698-702.
21. Waterman PE, McGann P, Snesrud E, Clifford RJ, Kwak YI, Munoz-Urbizo IP, et al. Bacterial Peritonitis Due to Acinetobacter baumannii Sequence Type 25 with Plasmid-Borne New Delhi Metallo-β -Lactamase in Honduras. Antimicrob Agents Chemother. 2013;57:4584-6.
22. NDM-1) in Acinetobacter schindleri during Routine Surveillance. J Clin Microbiol. 2013;51:1942-4.
23. NDM-1. Antimicrob Agents Chemother. 2012;56:6065-7.
24. NDM-1 in non-baumannii Acinetobacter spp. in China. J Antimicrob Chemother. 2012;67:2114-22.
25. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21:538-82.
26. Vila J, Marcos MA, Jimenez de Anta MT. A comparative study of different PCR-based DNA fingerprinting techniques for typing of the Acinetobacter calcoaceticus-A. baumannii complex. J Med Microbiol. 1996;44:482-9.
27. Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis. 2011;11:355-62.
28. Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, et al. Analysis of antibiotic resistance genes in multidrug-resistant acinetobacter sp. Isolates from military and civilian patients treated at the Walter reed army medical center. Antimicrob Agents Chemother. 2006;50:4114-23.
29. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 20th informational supplement. M100-S20-U. Wayne, PA: Clinical and Laboratory Standards Institute; 2010.
30. Sun Y, Song Y, Song H, Liu J, Wang P, Qiu S, et al. Complete genome sequence of an acinetobacter strain harboring the NDM-1 gene. Genome Announc. 2013;1:e0002312.
31. Do CB, Mahabhashyam MSP, Brudno M, Batzoglou S. ProbCons: probabilistic consistency-based multiple sequence alignment. Genome Res. 2005;15:330-40.
32. Guindon S, Dufayard J-F, Lefort V, Anisimova M, Hordijk W, Gascuel O. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol. 2010;59:307-21.
33. Darling AE, Mau B, Perna NT. progressiveMauve: multiple genome alignment with gene gain, loss and rearrangement. PLoS One. 2010;5:e11147.
34. Zhan Y, Yan Y, Zhang W, Yu H, Chen M, Lu W, et al. Genome sequence of Acinetobacter calcoaceticus PHEA-2, isolated from industry wastewater. J Bacteriol. 2011;193:2672-3.
35. Sahl JW, Gillece JD, Schupp JM, Waddell VG, Driebe EM, Engelthaler DM, et al. Evolution of a Pathogen: A Comparative Genomics Analysis Identifies a Genetic Pathway to Pathogenesis in Acinetobacter. PLoS ONE. 2013;8(1):e54287.
36. NDM-like genes in Acinetobacter baumannii. Antimicrob Agents Chemother. 2012;56:1087-9.
37. Vallenet D, Nordmann P, Barbe V, Poirel L, Mangenot S, Bataille E, et al. Comparative analysis of Acinetobacters: three genomes for three lifestyles. PLoS One. 2008;3:e1805.
38. Potron A, Poirel L, Croizé J, Chanteperdrix V, Nordmann P. Genetic and biochemical characterization of the first extended-spectrum CARB-type β -lactamase, RTG-4, from Acinetobacter baumannii. Antimicrob Agents Chemother. 2009;53:3010-6.
39. Rudant E, Courvalin P, Lambert T. Loss of intrinsic aminoglycoside resistance in Acinetobacter haemolyticus as a result of three distinct types of alterations in the aac (6')-Ig gene, including insertion of IS17. Antimicrob Agents Chemother. 1997;41:2646-51.
40. Towner KJ, Evans B, Villa L, Levi K, Hamouda A, Amyes SGB, et al. Distribution of intrinsic plasmid replicase genes and their association with carbapenem-hydrolyzing class D β -Lactamase genes in European clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother. 2011;55:2154-9.
41. Heddini A, Cars O, Qiang S, Tomson G. Antibiotic resistance in China-a major future challenge. Lancet. 2009;373:30.
42. NDM-1 bearing plasmid pNDM-BJ01 in Acinetobacter lwoffii. Wei Sheng Wu Xue Bao. 2013;53:99-104.
43. Kang SJ, Kang C-I, Park SY, Ha YE, Joo E-J, Chung DR, et al. Epidemiology and clinical features of community-onset Acinetobacter baumannii infections. Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am. 2012;33:1053-5.
44. Su S-Y, Chao C-M. Acinetobacter calcoaceticus-Acinetobacter baumannii complex is not equal to A. baumannii. Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am. 2013;34:215-6.
45. Lawley TD, Klimke WA, Gubbins MJ, Frost LS. F factor conjugation is a true type IV secretion system. FEMS Microbiol Lett. 2003;224:1-15.